Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,306,888
+$36,619 QoQ
Shares Held
8,339
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#550
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SITTNER & NELSON, LLC holds $15,187,262 across 14 Drug Manufacturers - General names. NVS ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,355 | $3,391,769 | |
| 2 | AMGN |
Amgen Inc
|
7,136 | $2,584,088 | |
| 3 | LLY |
ELI LILLY & Co
|
1,120 | $1,343,361 | |
| 4 | NVS |
Novartis AG
This page
|
8,339 | $1,306,888 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,398 | $1,232,952 | |
| 6 | PFE |
Pfizer Inc
|
43,693 | $1,052,127 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,165 | $1,049,202 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,100 | $1,023,354 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,306,888 | 8,339 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,270,269 | 8,316 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,167,207 | 8,466 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,079,396 | 8,417 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,018,541 | 8,417 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $950,812 | 8,529 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $829,956 | 8,529 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $981,005 | 8,529 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $933,547 | 8,769 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $874,922 | 9,045 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $908,931 | 9,002 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $969,197 | 9,515 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $980,340 | 9,715 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,254,696 | 13,638 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,232,159 | 13,582 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $990,942 | 13,037 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $962,543 | 11,387 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $889,521 | 10,137 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $874,525 | 9,998 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $793,102 | 9,698 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $840,776 | 9,215 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $766,328 | 8,965 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $844,676 | 8,945 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||